ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention
SHANGHAI, Oct. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug...
Read moreSHANGHAI, Oct. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug...
Read moreTAIPEI, Oct. 13, 2026 /PRNewswire/ -- Chia Cherne Industry Co., Ltd.'s President Ching-Sheng Kuo has been recognized as a Master Entrepreneur...
Read moreTAIPEI, Oct. 12, 2026 /PRNewswire/ -- ADATA Technology Co., Ltd. Founder and Chairman Simon Chen has been recognized with the...
Read moreSEOUL, South Korea, Oct. 13, 2026 /PRNewswire/ -- At KES 2026, the Korea Electronics Show, Fibocom is showcasing its LE270-KR...
Read moreLinking North American and Asia-Pacific Capabilities to Support Joint Sales and Project Execution SEOUL, South Korea and RALEIGH, N.C., Oct....
Read moreWilliam Contreras homered and drove in three runs as the Milwaukee Brewers beat the Los Angeles Dodgers 7-4 to take...
Read moreAsian equities fell sharply on Tuesday led by technology shares as a widening conflict in the Middle East kept oil...
Read moreRJ Mitte, the young actor best known for playing Walter White Jr in the award-winning TV series "Breaking Bad," has...
Read moreHyundai Commission: Tarek Atoui: Hold, the 11th Hyundai Commission, presents a major new multisensory installation by artist and composer Tarek...
Read moreCoventry earned a slice of Premier League history as they climbed out of the relegation zone with a stylish 4-1...
Read more
Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.
📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com
© 2025 by HKBusinesswire.com